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This month
marks my completion of four years as
a member of the leadership effort in
Troika, the last two of which I have
had the honor of serving as the
President of the Medical Staff. It has
been a tumultuous time for medicine
as well as local businesses. This
epoch saw 15 miles ofBethlehem
Steel factories come to a final
shutdown. Hess's was sold to the Bon
Ton and a 100 year tradition of a
downtown department store ended
abruptly. Mack Trucks moved most
of its operations and jobs to South
Carolina, and then later was bought
out by the French automotive giant
Renault.
In the health arena, the University of
Pennsylvania became one of the
richest hospital systems in America
and bought up dozens of primary care
offices in the surrounding region,
moving as far north as Quakertown.
They also acquired/merged with
hospitals including Phoenixville and
Pennsylvania Hospital. Hahnemann
University was bought out by
Allegheny, the Boston Brigham and
Women's and the Mass General
Hospital merged operations as did
Columbia Medical and Cornell, NYU,
and Mt. Sinai in New York. Closer to
home, St. Luke's merged with
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Allentown Osteopathic and bought
Quakertown Hospital outright. Lehigh
Valley Hospital formed a tighter
cooperative association with
Muhlenberg via a new regional
integrated delivery system which came
to be known as PennCARE.
Throughout it all, and perhaps because
of it, managed care markets thrived.
Once a small part of insurance
providers in the Lehigh Valley,
comprising less than 15 percent ofthe
market just four years ago, managed
care health systems burgeoned and are
anticipated to reach 40 percent in our
area by the turn of the century.
During this time, we have tried, as
Troika, to speak to the needs and
concerns of the medical staff, while
attempting to open channels of
communication throughout all levels
of our organization. At the same time,
we have tried to educate ourselves to
understand the forces of change so that
our staff can be prepared to adapt
professionally and smartly to them.
Wherever possible, we have sought to
build bridges of collaboration and
deliberation between physicians and
administration. In planning and
program building, we have been
tenacious to the principle of proactively seeking solutions to better
care of our patients in both a time
urgent and cost conscious fashion.
(Continued on Page 2)
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We have, I believe, achieved many of
these goals in the last two years, and,
as a medical staff and hospital, we
have much to celebrate.
We have strengthened our medical
school affiliation and educational ties
by becoming the chief clinical campus
for the Penn State Medical School at
Hershey. This has been crucial in the
support and nurturing of our hospital
medical staff residency programs and
in our performance improvement
efforts.
We have participated in the redesign
and re-engineering of our med/surg
floors in a way that improve~ the
efficiency and better focuses the care
delivery to patients. Pneumatic
"translogic" tubes have been installed
to deliver medications directly to
patient floors rather than waiting for
· hand delivery. Supplies and physical
therapy have moved from central
locations to the PCC units, and nurses
and radiologists have been outfitted
with portable cellular phones to
enhance the efficiency of
communication with clinicians. Faster
turnaround transcription times for
doctors dictations and report printing
directly to laser printers on the
hospital floor have helped improve the
timely flow of diagnostics about our
patients.
Information services has tied our
network of patients, physicians, and
caregivers together with an
increasingly more powerful PHAMIS
system which, gives us instant access
to patient laboratory and test results
and physician dictations. As more of
us have become proficient with the
power of e-mail, we have benefitted
from the ability to communicate

efficiently with each other throughout
the day virtually instantly and without
the persistent interruptions of phone
calls or pager "call parks."
Recognizing the cramped and
antediluvian space of the ER, we have
participated in the structural rebuilding
of emergency and radiological
services so they will better meet the
needs of all our patients, primary and
specialty physicians through the next
decade. Much more needs to be done
to accomplish smooth and time
efficient care through the ER, and we
remain committed to this goal in the
coming year.
The goal of consolidating inpatient
services came closer to realization as
we saw pediatrics, renal services, and
med/surg beds brought over to Cedar
Crest & 1-78. Commitments to bring
over psychiatry and obstetrics
services, ambulatory surgery, an
observation ER area, rebuilding our
ORs and ICUs while expanding
outpatient ambulatory services at 17th
& Chew will come to fruition with the
completion of the $52 million East
Wing building expansion,
unanimously endorsed by the Medical
Executive Committee and the Board
of Trustees last month.

In addition, during the past four years,
we as a staff have provided critical
input in the rebuilding of the GI and
dialysis lab, the Cath and EPS Lab, the
Cancer Center, Bum Unit at Cedar
Crest & 1-78, and in the creation of a
56-bed skilled nursing unit, new labor
and delivery suites, better outpatient
medical and dental clinic space, and
hospice center for the terminally ill at
17th & Chew.
(Continued on Page 3)
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As Troika, we have sought to provide
leadership advice in the area of
operations improvement which, in the
end, helps us all -- patient, doctor,
nurse, and community. This effort,
which includes hospital and clinical
services, has cut millions of dollars in
the expense of operations while
improving the quality of what we do.
A few examples include: A new
clinical, fully robotized laboratory
speeds the production of blood and
specimen processing while
dramatically cutting the cost.
Improved operations of the ORs cuts
costs in eliminating the waste of
opening unused sterile equipment.
Housekeeping services were
decentralized and improved to provide
better value for the effort.
Better diagnostic coding improved the
assessment of the level of complexity
of our care for patients while
simultaneously improving
reimbursement for services. We have
developed smarter handling of
universal precautions and removal and
incineration of hospital waste. Most
efficient use of med/surg· PCC space,
clinical guidelines and pathways,
better discharge planning, and an
aggressive team of home healthcare
services has enabled us to decrease
hospital length of stay dramatically
while at the same time increasing
patient satisfaction by independent
Press Ganey survey.
Another of our medical staff goals was
to foster development of a physician
hospital organization (PHO) and to
remain undivided in its support. Our
PHO has become 553 physician
members strong and has become the
sole contracting agency for insurance
providers to the hospital. Our

independent physician association
(IP A) and PHO contracting committee
has been unwavering in its
commitment to a strong primary care
network, giving primary care majority
control of our board and dedicated to
reimbursing primary care doctors "fair
plus" as has been articulated in a
"true" RBRVS system. With its
position in PennCARE, our PHO has
interdigitated with 2,000 physicians,
and 8 hospitals to better integrate and
cut the costs of delivery of quality
healthcare to our region through the
21st century.
As a medical staff, we should take this
moment to recall with pride our many
great accomplishments during the last
few years:
Cardiology has continued to be state of the
art and cutting edge from non-invasive
diagnostics to invasive angioplasty with Stent
placements and the diagnosis of difficult to
diagnose arrhythmias in the EPS lab. Our
cardiac surgery program has recently
reached a new statistical bench mark in
managing some of the highest difficulty of
surgical cases with the lowest morbidity and
mortality in the nation. Orthopedic surgeons
have refmed total knee and hip procedures
reaching yet higher standards in quality, cost
and length ofhospital stay. Vascular
surgeons at Lehigh Valley Hospital
performed carotid surgery for patients
enrolled in ACAS with among lowest
morbidity and mortality in the nation.
Outpatient procedures and surgery have
grown dramatically with the use of
laparoscopic surgical techniques developed
and perfected by many members of our
general surgical staff. Neurosurgery has
perfected stereotactic brain procedures and
with Radiation Oncology has spearheaded
the development of stereotactic radiosurgery
of brain lesions. The breast center was
launched through the John and Dorothy
Morgan Cancer Center, and stereotactic breast
biopsy offered a better approach to the
diagnosis and treatment of breast masses.

(Continued on Page 4)
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Radiation Therapy initiatives included
stereotactic radiotherapy, 3-D treatment
planning, and HDR (high dose rate remote
afterloading) brachytherapy. Transplant
surgery and surgical oncology grew
significantly at our center in the last few
years. Our Division of Geriatrics was rated
among the top in the nation by U.S. News and
World Report.
Radiology developed better and faster
services in CT and MRI and led the
development of non-invasive MRA for the
region. All of these were integrated with
PHAMIS to provide faster and immediate
transfer of diagnosis to clinician throughout
the organization. Better diagnostic ultrasound
for the carotid artery in the Vascular Lab and
the development of transcranial Doppler to
directly assess the cerebrovascular circulation
was brought on line. Neurology continued to
be a national leader with research at Lehigh
Valley Hospital in clinical trials of stroke,
epilepsy, multiple sclerosis and Alzheimer's
disease. In clinical areas, better non-invasive
diagnostics of syncope and epilepsy were
developed with video and ambulatory EEG, as
well as autonomic peripheral nerve testing.
Pelvic EMG was developed for the diagnosis
of incontinence syndromes. The use of
thrombolytic therapy and TCD cerebral
embolitic detection was integrated into the
comprehensive care of patients with acute
stroke.
The Department of Psychiatry saw nine peer
reviewed publications this year in areas of
outcomes of multidisciplinary mental health
treatments, stress and burnout management
and the interface of medicine and psychiatry
in treatment for trauma and cancer patients.
In addition, a new program was developed
initiating Behavioral Health services at
Cedarbrook Nursing Home, Cedar Crest
College and Life Path Developmental
Disabilities Organization in Bucks and Lehigh
County.
Pediatrics received national acclaim for their
participation in the Healthy Steps study.
Pediatricians at Lehigh Valley Hospital
became the fust functioning site of 25
nationwide launching a program of childhood
intervention and preventative care designed to
measure functional outcomes. The move of
the inpatient Pediatrics Unit from 17th &
Chew to newly constructed space at Cedar

Crest & I-78 resulted in the consolidation of
all pediatric non-intensive care inpatients to a
single floor, maintaining sufficient inpatient
census to support specialized services required
to meet unique needs of children. Through
the exceedingly generous gift of Ed and Inez
Donley, the Forrest G. Moyer Distinguished
Chair in Pediatrics was established which will
maintain Dr. Moyer's focus on education as
central to the provision of excellent clinical
care as an ongoing aspect of the culture of the
Pediatric Department. The practice
integration involving the hospital-based
pediatricians/neonatologists with ABC
Pediatrics and Family Pediatricians resulted in
24-hour coverage for the Pediatric clinic,
3,500 fewer Emergency Department Pediatric
visits while growing the clinic population by
25%, and a marked decrease in admissions for
children with complex medical problems.
Obstetrics and Gynecological physicians
completed a lengthy process and approved
preliminary plans for the new Labor and
Delivery, antepartum, perinatal and motherbaby unit for the East Wing project. In
addition, they assisted in the birth of over
3,500 babies last year, more than all of the
other hospitals in Allentown combined. The
residency program was strengthened and the
care of high risk pregnant mothers was vastly
improved. Under the leadership of Steve
Klasko, the new appointed Chair, the Perinatal
Partnership reported outcomes to the
community this year which included marked
reduced pre-term delivery rates and increased
employment post delivery. This, while
reducing LVHHN C-section rate to the lowest
of any tertiary care institution in our region.
The Pain Management Center was opened
by the Department of Anesthesiology and
the use of epidural analgesic pumps bettered
our care of inpatients with pain. Our trauma
program continued to be among the best in
the nation in research, diagnosis, care and
management of the multi-trauma patient, and
was accredited as a Level I Regional Resource
Trauma Center with additional qualifications
in pediatric trauma by the Pennsylvania
Trauma Systems Foundation.
The Department of Family Practice
recruited its fust residency class of five wellqualified graduates from five different U.S.
medical schools. Faculty participated with

(Continued on Page 5)
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members of the Internal Medicine division to
spearhead the development and
implementation of inpatient and outpatient
clinical pathways and guidelines.
In the Department of Medicine, the redesign
of the Cardiac Catheterization Laboratory
demonstrated a decrease in costs in the
laboratory. In an effort to implement an early
intervention program for patients with acute
myocardial infarction, the Acute Myocardial
Infarction Pathway was developed which
involved individuals from Emergency
Medicine, Cardiology, General Internal
Medicine, Family Practice, and the Pharmacy.
The Ventilator Management Program was
developed to assess patients within their ftrst
48 hours on respirator in an effort to early
weaning. The Critical Care Futility Pathway
was developed to assist patients and staff in
dealing with the important ethical issues
concerning futility ineffectual care. The
redesign of the operations of the
GI/Endoscopy Laboratory lead to decreased
costs. A number of cardiovascular research
studies, including the National Registry on
Myocardial Infarction and the Evaluation of
Second Generation Thrombolytics, were
completed. The development of the Diabetic
Foot Program, with participants from
Endocrinology, Plastic Slirgery, Podiatry, and
Physical Therapy, lead to a team approach in
the management of resistant ulcers.
Developing disease prevention and health
promotion became a major focus for our
hospital, supported by the Pool Trust, through
the launching of the Department of
Community Health & Health Studies at our
center with a mission to work within the
PennCARE region to improve health
outcomes. Recently, we were recognized by
the AAMC as one of 10 sentinel sites leading
the nation in this important area of health

care.
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I cannot close without extending
heartfelt thanks to the many people
who worked with us to accomplish
these goals. Especially let me thank
Joe Candio and Bob Murphy along
with my partners Larry Levitt, Peter
Barbour, Alex Rae-Grant and Chris
Wohlberg for their tireless support of

me. I would also like to express my
appreciation to the members of SMC,
Med Exec, and the Board of Trustees
who have taken much time to listen,
respect, and appropriately act on
behalf of our medical staff and on that
of our community of patients. Last,
but not least, let me thank John Hart,
Rita Mest, Beth Martin, Bess Ehnot,
Janet Seifert and Barbara Hallowell
for their cheerful and positive
administrative and secretarial support.
And what for the future? While no on
can predict with certainty, we can be
certain that the coming four years will
be as tumultuous and as volatile as the
last. I believe we have made great
progress in adapting and preparing for .
these changes as a staff and as an
institution, and I am certain that if we
maintain our focus on the patient and
keep open our channels of
communication, we will be well
positioned for many years to come.

On behalf of Joe Candio, Bob

Murphy, Dave Caccese and myself, I
would like to wish all of our hospital
family a happy and holy holiday
season and a prosperous and healthy
new year in 1997.

~

John E. Castaldo, MD
President, Medical Staff

There will be a General Medical
Staff meeting on Monday,
December 9, beginning at 5:30
p.m., in the Auditorium at Cedar
Crest & 1-78. All members of the
Medical Staff are encouraged to
attend.
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Medical Records Reminder
Medical record documentation is
essential for continuity of patient care as
well as serving as a tool for quality
assurance and reimbursement both from
the hospital and physician office
perspective. Recent studies indicated that
we are not meeting the requirements for
medical record completion according to
Lehigh Valley Hospital Medical Staff
Bylaws and JCAHO Accreditation
requirements.
Therefore, effective with the December 1
discharges/encounters, medical records
lacking histories and physicals and
operative reports will become delinquent
at the time of the next weekly suspension
(Wednesday following discharge/
encounter). Physicians and residents are
encouraged to complete histories and
physicals within 24 hours of admission
and prior to surgery. Operative reports
are to be completed immediately
following the procedure.

incomplete records by weekly letter and a
telep~one call.
If you have any questions or concerns
regarding this issue, please contact Zelda
Greene, Director, Medical Records, at
402-8330.

For Your Calendar
General Medical Staff .Meetings for 1997
are scheduled for:
• March 10
• June 9
• September 8 • December 8
Meetings will begin at 5:30 p.m. in the
Auditorium at Cedar Crest & 1-78.

•••••

Computerized Radiography in
the Emergency Room

As clarification of the vacation policy for
incomplete records, whenever a physician
notifies the Medical Record Department
that he/she is going on vacation, the clock
will stop on all medical records that need
to be completed. Histories and physicals
and operative reports will become
delinquent at the time of the next weekly
suspension process (Wednesday). All
other deficiencies will be placed on hold
while the physician in on vacation and
taken off hold when the physician returns.
(For example: A physician calls Medical
Records that he is going on a two-week
vacation. He has a record that has been
incomplete for five days. The clock stops
at this point. When the physician returns
in two weeks, the clock resumes at day
six.)

Since Spring of 1996, Computerized
Radiography has been functioning in the
Emergency Department at Cedar Crest &
1-78. In December, new software will be
installed. Training sessions will be
scheduled after the installation. If you
have any questions regarding
Computerized Radiography or need
instruction on the system as it currently
exists, please contact Cathleen Story,
Operations Coordinator, at 402-8297 or
through e-mail.

Physicians are encouraged to complete
medical records prior to patient discharge
to assure continuity of patient care. The

In addition, parking for Ambulatory
Surgery patients has been changed to Lot
2 at the comer of 17th & Chew. Please let
your patients know about this change prior
to their arrival at the hospital.

Medical Record Department will continue
to notify physicians/residents of

-----j

•••••

Ambulatory Surgery Unit Brochures
Please check your supply of brochures to
make sure you have the most recent
revision which lists the hotline number for
the Ambulatory Surgery Unit as 402-3400.

~~===~~d.~ )
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PHAMIS LastWord Upgrade
)

The PHAMIS LastWord 3.11 upgrade
is scheduled to begin activation on
January 17, 1997, with completion on
January 20, 1997. The four-day
interim is necessary to convert the data
from the old version to the new.
PHAMIS patient information will not
be available on-line during this fourday period. Downtime procedures (for
census, lab results, etc.) will be
published in the next issue of Medical
Sttiff Progress Notes and will be
posted in the Medical Staff Lounges.
Hands-on sessions of the PHAMIS
LastWord upgrade for physicians,
residents, allied health professionals,
and medical students will be offered in
December, 1996, and in January 1997.
These sessions are for those who are
currently using PHAMIS LastWord
and want to experience the new look
and feel of the upgrade.
The following is the schedule of
sessions being offered:
Wednesday, December 4,_1996
6 to 7:30pm - JDMCC, #401
Friday, December 6, 1996
6:30 to 8 am, JDMCC, #401
Monday, December 9, 1996
11 :30 pm to 1 pm - JDMCC, #401
5 to 6:30pm- JDMCC, #401
Tuesday, December 10, 1996
3:30 to 5 pm- JDMCC, #401
Wednesday, December 11, 1996
6 to 7:30pm- JDMCC, #401

)

Friday, December 13, 1996
6:30 to 8 am - JDMCC, #401

Monday, December 16, 1996
3:30 to 5 pm- JDMCC, #401
Tuesday, December 17, 1996
6:30 to 8 am- JDMCC, #401
Wednesday, December 18, 1996
6:30 to 8 am- JDMCC, #401
3:30 to 5 pm- JDMCC, #401
Thursday, December 19, 1996
5 to 6:30pm- JDMCC, #401
Monday, December 23, 1996
6 to 7:30pm- JDMCC, #401
Monday, January 6, 1997
5 to 6:30 pm - JDMCC, #401
Wednesday, January 8, 1997
6:30 to 8 am- JDMCC, #401
11 :30 am to 1 pm - 17 School of
Nursing
6 to 7:30pm- JDMCC, #401
Monday, January 13, 1997
3:30 to 5 pm- JDMCC, #401
6 to 7:30pm- JDMCC, #401
Wednesday, January 15, 1997
11:30 am to 1 pm- JDMCC, #401
3 to 4:30pm- JDMCC, #401
5 to 6:30pm- JDMCC, #401
Thursday, January 16, 1997
6:30 to 8 am- JDMCC, #401

Registration is required for all of
these sessions. The class size is
limited to 12 people. For more
information or to register for one of
these session, please call Information
Services at 402-1401.
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Prevention of Intravascular Device-Related Infection
After careful review of the recently
published Centers for Disease
Control's "Guideline for Prevention of
Intravascular Device-Related
Infections," the Infection Control
Depanrnenthasreconunendedthe
following practice changes in
intravascular device use and
maintenance. The new protocols will
begin to take effect in January, 1997.
Cutaneous Antiseptic
Chlorhexidine (Hibiclens) will be
the preferred cutaneous antiseptic.
Catheter - Site Dressing Regimen
Central Venous Catheters
NO antibiotic ointment should
be used (except on
hemodialysis catheters).
Transparent dressings may be
safely used. NOTE:
Tegaderm will be piloted in
MICU/SICU with the
anticipated use of this product
housewide.
Hemodialysis Catheters
Betadine ointment, sterile
gauze and microfoam.
NO transparent dressings.
Replacement of Catheters
Heparin Locks - replace very 96
hours
Pulmonary Arterial Catheters (PAC)
- mandatory statement for renewal at 5
days with 4 options:
1) Change PAC over a
guidewire;
2) Change PAC to a new site;
3) Discontinue PAC;
4) No Change - document
justification

)

There will be a sticker placed on the
physician order sheet which will assist
the process of renewal documentation
ofthe PAC.
Replacement of Pressure
Monitoring Devices
Disposable transducers, pressure
tubing and flush device and solution replace at 96 hour intervals.
Replacement of Administration Sets
Central Venous Catheters (CVC)replace tubing every 96 hours.
Total Parenteral Nutrition (TPN) replace tubing every 72 hours.
Umbilical Catheter- replace tubing
every 72 hours.
Replacement of Caps/Stopcocks
Replace with tubing changes at 96
hours unless visibly contaminated.

·----~

If you have any questions regarding
the new protocol, please contact the
Infection Control Department at
402-0680.

Happy

Holidays!
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News from the Library
)

Library Expansion Project
The Library expansion project at
Cedar Crest & I-78 will begin in the
near future and will be completed in
two phases over the next several
months.
Phase I entails creating an internal
doorway between the Library
circulation area and the recently
vacated Laboratory Administration
offices next door. These additional
rooms will provide quiet study areas
and shelving for specialized
collections and backfiles of journals.

·-j

Phase II entails the creation of a
Learning Resource Center which will
provide a classroom environment for
computer training and distancelearning through teleconferencing.
Details will be forthcoming.

Cardiac Puzzles
Author: Hurst, J. Willis
Call No. WG 141 H966c 1995
Managed Care and the Cardiac
Patient
Editor: Ott, Richard, et al.
Call No. W 125 M266 1994
The Textbook of Penetrating
Trauma
Editor: Ivatury, Rao
Call No. WO 700 T355 1995

It is anticipated that library services

Heart Diseases: A Textbook of
Cardiovascular Medicine, 5th
edition
Editor: Braunwald, Eugene
Call No. WG 200 H4364 1997
(Reference Section)

New Additions

Congratulations!

The following books are available in
the 17th & Chew Health Sciences
Library:

Alexander M. Rosenau, DO,
Department of Emergency Medicine,
was named medical director for the
Lehigh Valley International Airport
Firefighters. This group of
firefighters, 100% trained as EMS
quick responders, was trained and
certified in the application and use of
the automatic external defibrillator by
Dr. Rosenau and the regional EMS
training and rescue director.

will continue without disruption.

Clinical Periodontology, 8th edition
Author: Carranza, Fermin, Jr., et al.
Call No. WU 240 C641 1996
Practical Infection Control in
Dentistry, 2nd edition
Author: Cottone, James, et al.
Call No. WA 110 C851p 1995

)

Clinical Manual of Emergency
Pediatrics, Jrd edition
Editor: Crain, Ellen, et al.
Call No. WS 39 C641 1997

The following books are available in
the Cedar Crest & I-78 Health
Sciences Library:
Page9

Papers, Publications and Presentations
Jerome C. Deutsch, no, Department

of Emergency Medicine, presented an
indepth lecture on Emergency
Department Foreign Bodies A to Z at
the latest grand rounds of the
Emergency Medicine Residency of
the Lehigh Valley.

Houshang G. Hamadani, MD,

Department ofPsychiatry, gave a
poster presentation during the 1Oth
Wprld Congress of Psychiatry meeting
held August 23-28, in Madrid, Spain.

Joseph M. Jacobs, MD, Division of

Nephrology, recently had an article
published in the August issue of
American Journal of Kidney Diseases,
Vol. 28, No. 2, 1996. The article,
"Percutaneous Renal Artery Stent
Placement for Hypertension and
Azotemia: Pilot Study," evaluates the
efficacy of balloon-expandable stents
in the treatment of atheromatous renal
artery stenosis. The article was coauthored by John H. Rundback, MD,
of the Department ofRadiology, New
York Medical College.

Peter A. Keblish, MD, Chief,
Division of Orthopedic Surgery, was a
principal speaker at a mobile bearing
knee symposium in Marbella, Spain.
He delivered lectures on topics of
primary total joint replacement, partial
or uni-compartmental and revision
total knee surgery.
Dr. Keblish has been involved as
research investigator for moveable
bearing replacement, which is
accepted as the most advanced and
successful design in treatment ofknee
arthritis. Dr. Keblish is Director of the
Knee Learning Center at Lehigh

)

Valley Hospital and has hosted
hundreds of national and international
surgeons international surgeons
interested in total knee and hip
replacement.

lndru T. Khubchandani, MD,

Division of Colon and Rectal
Surgery, authored an article,
"Evolution and Current Practice of
Pull-Through Procedures," which was
published in the Journal of Pelvic
Surgery, Vol. 2, No. 3.

Larry N. Merkle, MD, Chief,
Division of Endocrinology/
Metabolism, co-authored a case report,
"Sertraline-Associated Syndrome of
Inappropriate Antidiuretic Hormone:
Case Report and Review of the
Literature," which was published in
Pharmacotherapy, Vol. 16, No.4.
A number of Lehigh Valley Hospital
physicians participated in the Eastern
Pennsylvania Regional EMS Council
Annual Conference, attended by 300
pre-hospital personnel October 25-27
at Pocono Manor. The Council's
Medical Director, Alex Rosenau, DO,
Department of Emergency Medicine,
lectured on Disaster Medicine,
Automatic External Defibrillator, and
New BLS Statewide Curriculum.
John F. McCarthy, DO, Chief,
Division ofPrehospital Emergency
Medical Services, spoke on Sensory
Deprived Tactile Assessment of the
Pre-hospital Patient. Mark D.
Cipolle, MD, Associate Chief,
Division of Trauma-Surgical Critical
Care, spoke on Pre-hospital
Traumatology.
(Continued on Page 11)
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Alex Rosenau, DO, also was a speaker at
the Third Annual Conference of the
Emergency Medicine Residency of the
Lehigh Valley held in Hershey, Pa. He
discussed the Pathophysiology and Prehospital and Emergency Evaluation and
Treatment of the COPD Patient.
Orion A. Rust, MD, Department of
Obstetrics and Gynecology, co-authored
two articles -- "Lowering the Threshold
for the Diagnosis of Gestational
Diabetes," and "Oral Terbutaline after
Parenteral Tocolysis: A Randomized,
Double-Blind, Placebo-Controlled Trial,"

which were published in the October
1996 issue of the American Journal of
Obstetrics and Gynecology. In addition,
Dr. Rust co-authored an article, "HighRisk Pregnancy," which was published in
the October, 1996 issue of Contemporary

OBIGYN.

James C. Weis, MD, Division of
Orthopedic Surgery, co-authored an
article, "In Vitro Biomechanical
Comparison ofMultistrand Cables with
Conventional Cervical Stabilization,"
which was published in Spine, Vol. 21,
No. 8, September, 1996.

Upcoming Seminars, Conferences and Meetings
Medical Staff/Administrative
Exchange Session
Due to the hectic schedules of many
individuals during this time of year, the
Medical Staff/Administrative Exchange
Session will NOT be held in December.

Regional Symposium Series
Orthopaedic Update: Elbow to the
Wrist: A Primary Care Approach will be
held on Saturday, December 7, from 7:30
a.m. to 1 p.m., in the hospital's Auditorium
at Cedar Crest & I-78.

An audiotape of
the Insulin

Resistance

,

Syndrome
symposium, held
on November9, is
available in the
Department of
Medicine. For
more information,

call Donna Kistler

-n

at 402-8200.

Orthopaedic surgeons, general practitioners,
physicians' assistants, physical therapists,
nurses, and other health professionals
interested in an update on orthopaedics will
benefit from the program.
At the completion of the program,
participants should be able to describe the
anatomy, signs, symptoms, diagnosis and
treatment of elbow to wrist problems in the
general population.
For more information about this program,
contact the Center for Educational
Development and Support at 402-1210.

Medical Grand Rounds
Medical Grand Rounds are held every
Tuesday from noon to 1 p.m., in the
hospital's Auditorium at Cedar Crest &
I-78.
Topics to be discussed in December
include: December 3- Endocrinology;
December I 0 - Ethics; and December 17 General Internal Medicine.
For more information, please contact Becky
Sherman in the Department of Medicine at
402-8200.

Department of Pediatrics
Indications for Sinus Surgery in Children
will be presented by Glenn Isaacson, MD,
Chief, Pediatric Otolaryngology and
Assistant Professor of Otolaryngology and
Pediatrics, St. Christopher's Hospital for
Children, Philadelphia, on Friday,
December 13, beginning at noon.
This program will be held in the hospital's
Auditorium at 17th & Chew. For more
information, please contact Kelli Ripperger
at 402-2540.
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Who's New
Medical Staff
Appointments
Anthony Brown, DO
Lehigh Valley Nephrology Associates
701 Ostrum Street
Suite 304
Bethlehem, PA 18015-1155
(610) 865-5888
FAX: (610) 865-1697
Department of Medicine
Division of Nephrology
Provisional Associate
William F. lobst, MD
LVPG-Medicine
1210 S. Cedar Crest Blvd.
Suite 3600
Allentown, PA 18103-6208
(610) 402-1150
FAX: (610) 402-1153
Department of Medicine
Division of Rheumatology
Provisional Active
David J. Meehan, MD
Family Pediatricians
401 N. 17th Street
Suite 109
Allentown, PA 18104-6804
(610) 435-6352
FAX: (610) 435-8950
Department of Pediatrics
Division of General Pediatrics
Provisional Active
Lori M. Proctor, DPM
(solo)
3885 Mechanicsville Road
Whitehall, PA 18052-3321
(610) 437-9343
Department of Surgery
Division of Orthopedic Surgery
Section of Foot and Ankle Surgery
Provisional Affiliate

Change ofStatus
William Gee, MD
Department of Surgery
Division of Vascular Surgery
From Active to Emeritus Active

Appointment to Medical Staff
Leadership Position

)

Thomas M. McLoughlin, Jr., MD
Department of Anesthesiology
Division of Cardiac Anesthesia
Chief, Division of Cardiac Anesthesia

Allied Health Professionals
Appointments
Megan Despard
Physician Extender
Surgical Technician
(Orthopaedic Associates of Allentown - Dr.
Respet)
Cheryl Faust, CRNA
Physician Extender
Professional - CRNA
(Allentown Anesthesia Associates- Dr.
Maffeo)
Charles A. Tucker, PA
Physician Extender
Physician Assistant
(Panebianco-Yip Heart Surgeons - Dr.
Yeisley)
Karen L. Voorhees, CRNA
Physician Extender
Professional - CRNA
(Allentown Anesthesia Associates- Dr.
Maffeo)

Change of Supervising
Physician
Jean D. Rohal, CRNP
Physician Extender
Professional- Nurse Practitioner
(Change from Michael Pasquale, MD to
Headley S. White, MD- Lehigh Valley
Health Center)

Resignation
Joan A. Dunski
Physician Extender
Technical
Dental Assistant
(George A. Kirchner, DDS)

)
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P & T HIGHLIGHTS

The following actions were taken at the August, September, October, 1996 Pharmacy and Therapeutics Committee Meeting
Maria Barr, Pharm.D., BCPS, Barbara Leri, Phann.D.

ACUTE MI PATHWAYTHERAPY GUIDELINES
FOR THROMBOLYTIC .
THERAPY AND PRIMARY
ANGIOPLASTY

)

Guidelines for the management of patients
with acute myocardial infarction have been
recently published. (JACK 28: Nov 1996;
1328-428). The guidelines emphasize the
importance of early diagnosis and prompt
initiation of·reperfusion therapy with either
a thrombolytic agent or primary
angioplasty.
The following tables summarize the
management guidelines and
contraindications for thrombolytic therapy.

TABLE 1- Diagnosis and Treatment
Measures in Patients with St Elevation or
Bundle Branch Block
Initial Diagnostic Measures
1.
Use continuous ECG, automated BP, HR
monitoring.
2.
Take targeted history (for AMI inclusions,
thrombolysis exclusions), check vital signs,
perform focused examination.
Start IV(s), draw blood for serum cardiac
3.
markers, hematology, chemistry, lipid
profile
4.
Obtain 12-lead ECG
5.
Obtain chest x-ray (preferably upright)

)

General Treatment Measures
1.
Aspirin, 160-325mg (chew and swallow)
2.
Nitroglycerin, sublingual: test for
Prinzmetal's angina, reversible spasm: antiischemic, antihypertensive effects
3.
Oxygen: sparse data; probably indicated,
first 2-3 h in all; continue if low arterial
oxygen saturation ( < 90%)
4.
Adequate analgesia: small doses of morphine
(2-4mg) as needed
Specific Treatment Measures
1.
Reperfusion therapy: goal - door-to-needle
time < 30 min: door-to-dilatation time
< 60 min
2.
Conjunctive antithrombotics: aspirin, heparin
(especially with r-tPt\)
3.
Adjunctive therapies: ,8-adrenoceptor
blockade if eligible, intravenous
nitroglycerin (for anti-ischemic or
antihypertensive effects), ACE inhibitor
(especially with large or anterior AMI, heart
failure without hypotension [SBP > lOOmm
Hg], previous Ml)
ECG indicates electrocardiogram: BP, blood pressure:
HR, heart rate; AMI, acute myocardial infarction;
IV's, intravenous administrations; r-tPA, (tissue
plasminogen activator); ACE, angiotensin converting
enzyme; SBP, systolic blood pressure.

TABLE 2 - Contraindications and
Cautions for Thrombolytic Use in
Myocardial lnfllTCtion •
Contraindications
Previous hemorrhagic stroke at any time;
other strokes or cerebrovascular events
within 1 year
Known intracranial neoplasm
Active internal bleeding (does not include
menses)
Suspected aortic dissection

Page 13

Cautions/relative contraindications
Severe uncontrolled hypertension on
presentation (blood pressure > 180/110 mm
Hg)t
History of prior cerebrovascular accident or
known intracerebral pathology not covered
in contraindications
Current use of anticoagulants in therapeutic
doses (INR ~2-3); known bleeding diathesis
Recent trauma (within 2-4 weeks), including
head trauma or traumatic or prolonged
( > 10 min) CPR or major surgery ( < 3 wk)
Noncompressible vascular punctures
Recent (within 2-4 weeks) internal bleeding
For streptokinase/anistreplase: prior
exposure (especially within 5 d-2y) or prior
allergic reaction
Pregnancy
Active peptic ulcer
History of chronic severe hypertension
INR indicates International Normalized Ratio: CPR,
cardiopulmonary resuscitation. • Viewed as advisory
for clinical decision making and may not be allinclusive or definitive. t Could be an absolute
contraindication in low-risk patients with myocardial
infarction (see text).

The guidelines advise thrombolytic therapy
be administered to patients with clinical
features of acute MI in association with ST
elevation ( > 0.1mV in two or more
contiguous leads) or bundle branch block
in patients presenting < 12 hours from the
onset of symptoms. It was emphasized
that the outcome would be better if
treatment was initiated early, with the
greatest benefit derived when treatment
was begun within 3 hours. These
recommendations apply to patients > 75
years of age as well as younger patients.
It was not advocated for r-tPA to be usesd
for all patients with acute MI. Although
GUSTO found a mortality advantage of rtP A when compared to streptokinase
(NEJM, 329, 1993; 674-681), this
statistical difference was not considered
clinically significant by the members of the
consensus committees.

The guidelines emphasized that r-tP A, in
addition to the follow-up clinical markers:
age > 65, low body weight ( < 70kg) or
hypertension on presentation (systolic BP
> 180 mmHg or diastolic BP > 110
mmHg) increased the risk of intracranial
hemorrhage, therefore in patients with two
or more clinical risk factors consideration
should be given to utilizing streptokinase
or primary angioplasty as an alternative to
r-tPA.
They advise PTCA as an alternative to
thrombolytic only if perfonned in a timely
fashion (60-90 minutes from time of
diagnosis) by individuals skilled in the
procedure (documented success rate with
TIMI II-III flow in > 90% of patients and
mortality< 12% ), in an institution with
rapid access to cardiac surgery.

CONVERT WITH
COR VERT R - A NEW
CLASS III
ANTIARRHYTHMIC
AGENT

)

Ibutilide (CorvertR}, an injectable class III
antiarrhythmic agent, has been approved
for addition to the LVH fonnulary
restricted to cardiology use. The agent is
indicated for the rapid conversion of recent
onset atrial fibrillation or arterial flutter.
Safety and efficacy studies show ibutilide
as more efficacious than sotolol and at
least equiefficacious as procainamide with
better tolerability. Electrophysiologic
effects include mild slowing of the sinus
rate and AV conduction as well as dose
related QTc prolongation. QTc
prolongation will return to a baseline as
the drug is eliminated over 4-6 hours after
a single 1mg dose. Adverse effects
include headache, nausea and
proarrhythmias. The reported incidence of

)
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proarrhythmias is 1. 7% based on clinical
trials.

insulin in patients requiring additive
therapy for controlled of their disease.

Dosing of ibutilide begins with a 1mg IV
infusion over 10 minutes. A physician
MUST be present during each dosing
period. The manufacturer recommends a
lower dosage for patients weighing <
60Kg. The patient must have continuous
ECG monitoring during dosing and for at
least 4-6 hours post dose until QTc returns
to baseline. A second 1mg dose of
ibutilide over 10 minutes may be
administered if the first dose is ineffective.
A 20-30 minute interval should be allowed
between dosages.

Glimepiride works similarly to take other
sulfonylureas stimulating the release of
insulin from functioning beta cells and
improving insulin sensitivity of peripheral
tissues. Insulin release is stimulated by
glimepiride in a dose-related manner
reaching its maximum glucose lowering
effects in approximately 2-3 hours after
administration and maintaining the glucose
lowering effect for 24 hours.

Patient selection and monitoring are key to
the safety and efficacy of ibutilide.
Caution must be used in patients receiving
other class III agents (i.e. amiodarone) or
class lA agents (i.e. procainamide) since
the risk of QTc prolongation and
proarrhythmias may be increased. Insure
a normal serum potassium ( > 3 .5) and
magnesium (L 1. 7) before treatment.
Pretreatment with magnesium 8-16mEq
may be considered for patients with
normal renal function. In the event
torsodes de pointes occurs, treat
accordingly by stopping the ibutilide and
administering IV magnesium in lgm-2gm
dosages. Electric cardioversion may be
required, therefore, an emergency code
cart should be in close proximity.

GET THAT SUGAR
UNDER CONTROL!

)

Glimepiride (AmarylR, Hoechst-MarionRoussel) is a sulfonylurea indicated as an
adjunct to diet and exercise to lower blood
glucose in patients with NIDDM whose
hyperglycemia cannot be controlled with
diet and exercise alone. It is also
indicated to be used in combination with

The most common adverse effects during
glimepiride therapy include hypoglycemia,
dizziness, headache and nausea.
The hypoglycemic effects may be
potentiated by other medication including
insulin, NSAIDS, and other highly protein
bound medications. Caution should be
exercised when using these agents
concurrently with glimepiride. Agents
which may result in hyperglycemia and
loss of glucose control with glimepiride
include thiazides and other diuretics,
corticosteroids, phenothiazines, thyroid
products, estrogen, oral contraceptives,
phenytoin, sympathomimetics and
isoniazid.
The usual dosing of glimepiride is 1-2 mg
once daily given with breakfast or the first
main meal of the day. In patients who
may be more sensitive to the hypoglycemic
effects or renally impaired should be
started on the lower dose of 1mg. This
usual maintenance dose is 1-2mg daily
with the maximum dose of 8mg/day.
Fasting blood glucose should be
periodically monitored in addition to
glycosolated hemoglobin every 3-6
months.
Some potential advantages of glimepiride
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compared to currently available agents
include once daily administration, possibly
leading to increased compliance, a lower
risk of hypoglycemia and potential for less
insulin resistance.
The major disadvantage of the addition of
this agent to formulary is the potential
increased cost of glimepiride.
Inpatient cost/ dose

AWP cost/dose

glimepiride lmg
2 mg
4mg

$0.18
$0.30
$0.57

$0.22
$0.37
$0.70

glyburide 1.25mg
2.5mg
5mg

$0.06
$0.14
$0.21

$0.17
$0.23
$0.42

glipizide 5mg

$0.12

$0.32

*Based on AWP or pharmacy cost

Though expensive, the increase in glucose
control of these patients with glimepiride
may lead to improved disease control.

HUMALOG - INSUUN LISPRO
(LIUY)

The long awaited insulin is finally released
and available at LVH! Years of research
has resulted in the approval of a new
insulin to treat patients with type I and II
diabetes mellitus.

Insulin lispro is an insulin analog of
recombinant DNA origin, different from
regular human insulin by an inversion of
the amino acid sequence of the insulin beta
chain at position 28 and 29. The result is
an insulin analog which is more rapidly
absorbed, produces higher peak
concentrations and lower postprandial
blood glucose levels and is eliminated
faster than other regular insulins.
Additionally, this new analog may be
beneficial in treatment of patients with
antibody-mediated resistance to regular

human insulin because of the structural
difference of the molecule.
When insulin lispro is injected, just prior
to eating, it mimics the postprandial
glucose homeostasis of nondiabetic
subjects and decreases the risk of
postprandial hypoglycemia.
In comparative trials, insulin lispro
produced better results in postprandial
blood glucose control then regular human
insulin in both type I and II diabetics.
Adverse effects associated with insulin
lispro are similar to those observed with
regular human insulin. There appears to
be an equal or lower rate of hypoglycemic
episodes and no difference with respect to
local or systemic allergic reactions,
lipodystrophy or injection site reactions
compared to regular human insulin.

)

The dosing of insulin lispro is similar to
that of regular human insulin.
Administration of insulin lispro just prior
to eating will produce the desired effects
while with regular human insulin the dose
should be administered 30-60 minutes
prior to eating, which may be more
convenient for patients.
All patients receiving insulin lispro should
periodically monitor blood glucose levels.
However patients switching from regular
human insulin to insulin lispro should be
monitored closely to determine if any
alternations in dose or schedule is
necessary. In addition the dose may need
to be increased with high carbohydrate
meals to avoid postprandial hypoglycemia
and decreased with high fat meals to avoid
postprandial hypoglycemia.
As with glimepiride, insulin lispro is more
costly compared to regular human insulin.

)
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The comparative costs are as follows for a
1OOunits/ml 1Oml vial.

AWP

insulin lispro
$20.82
regular human insulin $ 8.12
(Novulin-R)

$24.98
$15.70

When using lispro together with
longer acting agents such as NPH, the
mixing of the agents remains the same.

FENTANYL PATCHES
FOR CHRONIC PAIN
ONLY- NOT POST-OP!

An increase in the utilization of fentanyl
patches for post-operative pain
management has been noted throughout the
institution. This product is approved and
should only be utilized as part of a
regimen for chronic pain management.

)

The patch may take 8-12 hours to take its
full effect but may produce over-sedation
in post-operative period delaying or
prolonging the patients progress.
It is recommended that shorter acting
round-the-clock or "pm- as needed"
agents be utilized initially post-op and
tapered over the following days following
the procedure. Due to fentanyl's 72 hours
duration of action, titration of pain relief is
difficult and even after the patch is
removed may continue to sustain its effects
due to the depot effect of the medication.

A MACROLIDE OR
AZOLIDE- IT'S YOUR
CHOICE
)

The L VH formulary contains erythromycin
IV and PO as well as both clarithromycin
(BiaxinR) and azithromycin (ZithromaxR).

Therapeutic decisions should be based on
each individual patient's clinical situation.
A few differences are apparent among the
three agents available. A key difference is
the administration with regards to meals.
Azithromycin MUST be given on an
empty stomach. As LVH, the dosing time
for azithromycin is 0700 to avoid the fooddrug interaction. Avoiding this interaction
is more difficult for patient's on
continuous enteral feedings. Erythromycin
or clarithromycin, on the other hand, can
be administered without regards to. meals.
It is also important to note the differences
in drug-drug interactions. Azithromycin is
often chosen due to once daily, 5-day
administration and lack of significant drugdrug interactions. The following table is
provided to summarize the differences
amont the agents with respect to meals
and concomitant medication.
MACROLIDEIAZOLIDE DRUG INTERACTIONS
Azilhro

Food/enteral

Avoid

Antacids

Avoid

Clarithro

Erylhro (Base)

Avold

t.mi!!il!!mil!!§
Avoid

utemlzole
(llismaiW")

Avoid

loratadlne

Avoid

Avoid

terfeaadlae
(Seidane ")

Avoid

Avoid

cetrlzlae
(Z7!'1ecA)

Safe

clsaprlde
(Propulcld•)

Safe

cyc:lolporiDe

Safe

carbamazeplne

Safe

Safe

Avoid

Avoid

Safe

••
••

••
••

taerollnuu

Safe

••

••

theophyUIDe

Safe

warfarin
(CoumadiD•)

Safe

(Tqretol•)

(Pro1rafA)

••
••

..
..

Anid • ilunalon -ovoid CDIICOIDIIIilln lllmiailllllion
Sift •DO druf -..uons

•• • DNr·Drur ~ ,....lriftllllllllilorinllllld possible dale chlnJes
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FYI

OCU-MYCIJVil - THE
SAME NAME BUT, NOT
THE SAME DRUG

Ocu-MycinR, an antimicrobial ophthalmic
preparation, previously known as a triple
antibiotic preparation has changed.
Bausch-Lomb had previously marketed
Ocu-MycinR as Bacitracin/Neomycin/
Polysporin and now supplies this
formulation generically. The trade name,
Ocu-MycinR, is now a different product
from a different manufacturer. OcuMycinR is now, gentamicin ophthalmic
product.
Please be specific in your orders for
ophthalmic antimicrobial agents. To avoid
confusion with the order for either a
gentamicin ophthalmic preparation or
Bacitracin/Neomycin/Polysporin or
Bacitracin!Polymixin.

PARENTERAL
HYDRALAZINE UNAVAILABLE UNTIL
FURTHER NOTICE!

)

Due to a nationwide shortage, the
manufacturers of parenteral hydralazine
have been unable too supply the drug and
LVH has exhausted its complete supply.
The oral formulation will continue to be
available. Alternative parenteral agents
such as nitroprusside, enalaprilat injection
(Vasotec), or possibly a dihydroperidine
calcium channel antagonist such as
nifedipine PO/NG or nicardipine injection
will need to be used during the shortage.
Please share this information with your
colleagues.

)

)

pl\1096.hi
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Academic Information
and Media Services

._,

)

News and. Notes
PowerPoint Training
Why not sign up for a Microsoft PowerPoint 4.0
class now? Then you'll
be all set when it shows
up under your tree.
Module I (Introduction) covers the basics of
PowerPoint and allows you to create a simple slide or
computer show. Prerequisite for this class is a
• knowledge of Windows.

December, 1996
Physician Workshops
Computer workshops for physicians
are offered on:

OVID, Micromedex, OPAC & Internet
Tuesday, Dec. 10, 5:30pm-7:30pm
This workshop will cover the basic functions of
each of the applications and how their usage can
best be integrated into our daily job functions.
Included will be an overview of the OVID
databases, Micromedex Drug Interactions, how
to use the automated card catalog (OPAC), and
an introduction to the biomedical information
available on the internet.

Module I classes are:
Friday,
Dec. 13, 1300-1600, JDMCC liS Classroom
Tuesday, Dec. 17, 1700-2000, JDMCC 1/S Classroom
Module II (Intermediate) covers some more
advanced features of PowerPoint including charts,
graphs and customizing certain PowerPoint features.
Prerequisite for Module II is completion of Module I.

)

Module II classes are:
Monday, Dec. 2, 1300-1600,
Filled
Friday,
Dec. 6, 0900-1200, JDMCC liS Classroom
Monday, Dec. 16, 0900-1200, JDMCC 1/S Classroom
Module Ill (Advanced) classes are still being
planned; however, the December beginning date
for these classes has been extended into January.
PLEASE NOTE: If the times listed for scheduled
classes are not convenient, please let us know what
time would be best for you. We can usually make
arrangements to do smaller groups or even one-toone instruction if necessary. To register, or for more
information, please e-mail Dean Shaffer in the AIMS
department (or phone x-0055). Class size is limited.

• •

AIMS Request Forms

)

The AIMS_Forms (found in
E-mail Bulletin Board) should be
used when requesting:
•Audio/Visual Equipment Reservations
• Video Conferencing
•Satellite Teleconferencing

The Internet
Monday, Dec. 16, 5:00pm-7:00pm
An introduction to the internet and techniques
to access on-line medical information.
The Physician Workshops are hands-on. Call the
library at 402-8410 to register. All applications
are available via the hospital network. You do
not need to have the internet icon, but it is
suggested. Both Netscape and the Internet Icon
are covered. To obtain the icons, contact Pat
Skrovanek in the POPS office, 402-9859.

CME On-line Web Sites
Q
http://www.acponline.org
The American College of Physicians' Web site. Contains
calendar of CME courses and information resources

Q
http://www.amaassn.org/iwcf/iwcfmgr/cme
American Medical Association database of more than
2,000 CME resources
Q
bttp://www.cmea.com
A list ofCME on CD-ROM available from Continuing
Medical Education Associates

Q
http://www.immunet.org/meded
On-line courses for CME on AIDS and HIV topics from
Healthcare Communications Group
http://www.medconnect.com/
tinalhtm/intacedu.btm
Lectures on new topics each month with interactive quiz
from Interactive Education
Q
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and Media Services

PowerPoint - The Answers
Since the Academic Information and Media Services
(AIMS) Department has begun offering PowerPoint
classes to interested physicians, some questions
regarding access and LVH policy have arisen. Here
are some of the more frequently asked questions.
Who purchases the software?
Each physician is responsible for purchasing his or her
own software (or license). For hospital related projects,
if you feel that the hospital should purchase the
software for you, contact your respective department. It
is the department's responsibility to discern the validity
of the request and order through their own cost center.
How much does PowerPoint cost?
A workstation license to hook up to the hospital's
server is $43. The standalone version of the software
costs $85 from the hospital's vendor. Check with your
department for the proper Information Services contact
person ..
What workstations in the hospital already have
PowerPoint available for use?
There are two workstations in the CC library and one
workstation in the physician's lounge. There is,
however, no printer to print your PowerPoint
presentations in the lounge.
How and where do I save my presentation? You
can save your presentation on a 3 .5" floppy disk. Go
to File, Save As, and in the Drives section, choose
the A: drive. Don't forget to name your presentation
first. To reopen a saved file, go to File, Open, and
specify the name of the presentation and on which
drive it is located.
I have a Macintosh computer. Can I use this
PowerPoint disk at the hospital?
You can open Macintosh PowerPoint 4 presentations
in Windows. If you have a Macintosh PowerPoint 3
presentation, you have to open the presentation in
Macintosh PowerPoint 4 before converting it to
Windows; or, convert the presentation to Windows
PowerPoint 3, then open it in PowerPoint 4 for
Windows.

I want to make my slides at home on my
Windows 95 computer. Can I bring the
program to the hospital and show it? Windows
95 PowerPoint programs are not compatible with
the hospital's Windows 3.1 system. However, if
you save your Windows 95 program (PowerPoint
version 7) as a PowerPoint Version 4.0 [File,
Save as type: PowerPoint 4.0], you can then
bring the disk to the hospital to show your
program. (Note: you may lose some background
information and/or font styles when converting
from PPT v. 7 to PPT v.4. We are currently
working to reduce or eliminate these problems.)
Can I still bring my work to Photo/Graphic
Services and have them make slides for me?
Photo/Graphic Services will make your slides for you
if .the slides will be used for public presentations
outside the hospital (or presentations in the hospital
that are for the public).
For in-house presentations, we are encouraging you
to make your own slides in PowerPoint. For those who
do not know how (nor want to learn how) to make
their own slides, we can make copy slides for you
from your typewritten material. (We do request clean
copy with high quality black print for best results.)
For details, contact Photo/Graphic Services ext-8511.
How do I show my work?
Use of the video projection system in the Cedar
Crest auditorium is encouraged. A portable
projector for resident education programs is also
available. A projection panel is available as well.
Contact Gary Weisel, A.V. Services at ext. 8325
or via e-mail for training on the use of the video
projection system in the auditorium.
lfyou have any questions, please contact the
AIMS Media Specialist at ext.-0055.
Suggestions and ideas are always welcome. /f.vou would like to
see a particular topic addressed, please contact Christopher
Sarley, ext. I 64 I, or Dean Shaffer, ext. 0055. Both are available
via E-mail.
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